JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
The relationship between uric acid variability and cardiovascular risk factors in patients with diabetes
Abstract
Aims: This study aimed to evaluate the relationship between uric acid variability and cardiovascular risk factors, primarily albuminuria and blood lipids, in patients with diabetes. Material and
Methods: Data from 174 patients with diabetes whose biochemical parameters were examined at least once a year were collected over the course of five years of regular follow-up. The five-year averages and standard deviations of each parameter for each person were calculated. The adjusted standard deviation for each parameter was considered as a measure of individual variability. The patients were divided into two groups according to the median of the mean uric acid and the median of the adjusted standard deviation of uric acid.
Results: Between low and high uric acid variability groups, while there was no statistically significant difference for the mean values of following parameters, there was a difference in the variability of glucose (p=0.010), HbA1c (p=0.016), total cholesterol (p=0.008), and low-density lipoprotein-cholesterol (p=0.002). Moreover, there was difference in mean albuminuria (p= 0.019), albuminuria variability (p=0.040), mean triglyceride (p=0.011), triglyceride variability (p=0.018), and mean high-density lipoprotein-cholesterol cholesterol (p=0.008).
Conclusion: Clinicians should pay attention to uric acid variability in addition to basal uric acid levels since it is associated with albuminuria, an atherogenic lipid profile, renal functions, and the variability of these parameters, independent of HbA1c and glucose levels.

Keywords : Uric acid, diabetes mellitus, albuminuria, dyslipidemia, cardiovascular disease

Download Article


1. International Diabetes Federation. IDF Diabetes Atlas, Brussels,Belgium.: International Diabetes Federation; 2021. 10thedn.:[Available from: https://www.diabetesatlas.org.
2. Yoo TW, Sung KC, Shin HS, et al. Relationship between serumuric acid concentration and insulin resistance and metabolicsyndrome. Circ J 2005; 69: 928-33.
3. Qin T, Zhou X, Wang J, et al. Hyperuricemia and the prognosis ofhypertensive patients: a systematic review and meta-analysis. JClin Hypertens 2016; 18: 1268-78.
4. Juraschek SP, McAdams-Demarco M, Miller ER, et al. Temporalrelationship between uric acid concentration and risk of diabetesin a community-based study population. Am J Epidemiol 2014;179: 684-91.
5. Kuwabara M, Borghi C, Cicero AF, et al. Elevated serum uricacid increases risks for developing high LDL cholesterol andhypertriglyceridemia: A five-year cohort study in Japan. Int JCardiol 2018; 261: 183-8.
6. Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk.N Engl J Med 2008; 359: 1811-21.
7. Akbas EM, Timuroglu A, Ozcicek A, et al. Association of uricacid, atherogenic index of plasma and albuminuria in diabetesmellitus. Int J Clin Exp Med 2014; 7: 5737-43.
8. Fang J, Alderman MH. Serum uric acid and cardiovascularmortality: the NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000; 283: 2404-10.
9. Konta T, Ichikawa K, Kawasaki R, et al. Association betweenserum uric acid levels and mortality: a nationwide community-based cohort study. Sci Rep 2020; 10: 1-7.
10. Cho SK, Chang Y, Kim I, Ryu S. U-shaped association betweenserum uric acid level and risk of mortality: a cohort study.Arthritis Rheumatol 2018; 70: 1122-32.
11. Hu L, Hu G, Xu BP, et al. U-shaped association of serum uric acidwith all-cause and cause-specific mortality in US adults: a cohortstudy. J Clin Endocrinol Metab 2020; 105: e597-e609.
12. Cheong E, Ryu S, Lee J-Y, et al. Association between serum uricacid and cardiovascular mortality and all-cause mortality: acohort study. J Hypertens 2017; 35: S3-S9.
13. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acidand risk for cardiovascular disease and death: the FraminghamHeart Study. Ann Intern Med 1999; 131: 7-13.
14. Wang M, Wang C, Zhao M, et al. Uric acid variability and all-cause mortality: a prospective cohort study in northern China. JNutr Health Aging 2021; 25: 1235-40.
15. Grossman C, Grossman E, Goldbourt U. Uric acid variability atmidlife as an independent predictor of coronary heart disease andall-cause mortality. PLoS One 2019; 14: e0220532.
16. Dong ZX, Tian M, Li H, et al. Association of serum uric acidconcentration and its change with cardiovascular death and all-cause mortality. Dis Markers 2020; 2020: 7646384.
17. Lim SS, Yang Y-L, Chen S-C, et al. Association of variability inuric acid and future clinical outcomes of patient with coronaryartery disease undergoing percutaneous coronary intervention.Atherosclerosis 2020; 297: 40-6.
18. Ceriello A, De Cosmo S, Rossi MC, et al. Variability in HbA1c,blood pressure, lipid parameters and serum uric acid, and riskof development of chronic kidney disease in type 2 diabetes.Diabetes, Obesity and Metabolism 2017; 19: 1570-8.
19. Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the riskof microvascular complications in type 1 diabetes: data from theDiabetes Control and Complications Trial. Diabetes Care 2008;31: 2198-202.
20. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN. Effectof glycemic exposure on the risk of microvascular complicationsin the diabetes control and complications trial--revisited. Diabetes2008; 57: 995-1001.
21. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significanceof visit-to-visit variability, maximum systolic blood pressure, andepisodic hypertension. Lancet 2010; 375: 895-905.
22. Cavarretta E, Frati G, Sciarretta S. Visit-to-visit systolic bloodpressure variability and cardiovascular outcomes: new data froma real-world Korean population. Am J Hypertens 2017; 30: 550-3.
23. Rothwell PM. Limitations of the usual blood-pressurehypothesis and importance of variability, instability, and episodichypertension. Lancet 2010; 375: 938-48.
24. Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, CerielloA. Glucose variability: An emerging target for the treatment ofdiabetes mellitus. Diabetes Res Clin Pract 2013; 102: 86-95.
25. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit bloodpressure variability is a novel risk factor for the developmentand progression of diabetic nephropathy in patients with type 2diabetes. Diabetes Care 2013; 36: 1908-12.
26. Hamm P, Shekelle RB, Stamler J. Large fluctuations in body weightduring young adulthood and twenty-five-year risk of coronarydeath in men. Am J Epidemiol 1989; 129: 312-8.
27. Bangalore S, Fayyad R, Laskey R, DeMicco DA, Messerli FH,Waters DD. Body-weight fluctuations and outcomes in coronarydisease. N Engl J Med 2017; 376: 1332-40.
28. Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension,progressive renal disease, and uric acid: a pathogenetic link? J AmSoc Nephrol 2005; 16: 1909-19.
29. Lytvyn Y, Perkins BA, Cherney DZ. Uric acid as a biomarker anda therapeutic target in diabetes. Can J Diabetes 2015; 39: 239-46.
30. Brovold H, Lund T, Svistounov D, et al. Crystallized but notsoluble uric acid elicits pro-inflammatory response in short-termwhole blood cultures from healthy men. Sci Rep 2019; 9: 10513.
Article available in :
Volume 6, Issue 2, 2023
Page : 513-518
https://doi.org/10.32322/jhsm.1226971
Article Information
Received : 30 Ara 2022
Accepted : 07 Mar 2023
Published : 27 Mar 2023
Corresponding Author :

Nergis Akbaş: Department of Medical Biochemistry, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey

[email protected]
Citation : Akbaş EM, Akbaş N. The relationship between uric acid variability and cardiovascular risk factors in patients with diabetes. J Health Sci Med 2023; 6(2): 513-518.

Read: 142
Cited: 0
Download : 99
_Footer